0001209191-21-011401.txt : 20210217 0001209191-21-011401.hdr.sgml : 20210217 20210217174058 ACCESSION NUMBER: 0001209191-21-011401 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210215 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kopczynski Casey C. CENTRAL INDEX KEY: 0001590001 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 21646467 MAIL ADDRESS: STREET 1: 135 U.S. HIGHWAY 206 STREET 2: SUITE 15 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: (919) 237-5300 MAIL ADDRESS: STREET 1: 4301 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-15 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001590001 Kopczynski Casey C. C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 0 1 0 0 Chief Scientific Officer Common Stock 2021-02-15 4 M 0 60651 0.196 A 265522 D Common Stock 2021-02-15 4 F 0 725 16.41 D 264797 D Stock Option (right to buy) 0.196 2021-02-15 4 M 0 60651 0.00 D 2021-04-28 Common Stock 60651 0 D This option is fully vested and exercisable. If not exercised, the option would have expired on April 28, 2021. /s/ John LaRocca, Attorney-in-Fact for Casey C. Kopczynski 2021-02-17